Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Read

Showing results (701-710 of 723) with videos related to

Pageof 73
Sort By:
The European Respiratory Journal|November 23, 2023
The impact of outpatient <i>versus</i> inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trialParthipan Sivakumar, Deirdre B Fitzgerald, Hugh Ip, et al.
The New England Journal of Medicine|January 30, 2020
Conservative versus Interventional Treatment for Spontaneous PneumothoraxSimon G A Brown, Emma L Ball, Kyle Perrin, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|November 22, 2021
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 MethyltransferaseSharan K Bagal, Clare Gregson, Daniel H O' Donovan, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Trials|June 27, 2022
Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusionDeirdre B Fitzgerald, Calvin Sidhu, Charley Budgeon, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): A Pilot Randomized Clinical TrialDeirdre B Fitzgerald, Grant W Waterer, Charley Budgeon, et al.
Biopolymers|January 12, 2019
Peptoids advance multidisciplinary research and undergraduate education in parallel: Sequence effects on conformation and lipid interactionsChristian J Jimenez, Jiacheng Tan, Kalli M Dowell, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clusteringJeffrey W Johannes, Lynsie Almeida, Kevin Daly, et al.
Pageof 73

Showing results (701-710 of 723) with videos related to

Sort By:
Pageof 73
The European Respiratory Journal|November 23, 2023
The impact of outpatient <i>versus</i> inpatient management on health-related quality of life outcomes for patients with malignant pleural effusion: the OPTIMUM randomised clinical trialParthipan Sivakumar, Deirdre B Fitzgerald, Hugh Ip, et al.
The New England Journal of Medicine|January 30, 2020
Conservative versus Interventional Treatment for Spontaneous PneumothoraxSimon G A Brown, Emma L Ball, Kyle Perrin, et al.
Clinical and Experimental Immunology|August 1, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitisS C Sasson, J J Zaunders, K Nahar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Journal of Medicinal Chemistry|November 22, 2021
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 MethyltransferaseSharan K Bagal, Clare Gregson, Daniel H O' Donovan, et al.
Journal of Medicinal Chemistry|October 10, 2008
Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonistsMartin R Tremblay, Marta Nevalainen, Somarajan J Nair, et al.
Trials|June 27, 2022
Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusionDeirdre B Fitzgerald, Calvin Sidhu, Charley Budgeon, et al.
American Journal of Respiratory and Critical Care Medicine|January 26, 2022
Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): A Pilot Randomized Clinical TrialDeirdre B Fitzgerald, Grant W Waterer, Charley Budgeon, et al.
Biopolymers|January 12, 2019
Peptoids advance multidisciplinary research and undergraduate education in parallel: Sequence effects on conformation and lipid interactionsChristian J Jimenez, Jiacheng Tan, Kalli M Dowell, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2015
Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clusteringJeffrey W Johannes, Lynsie Almeida, Kevin Daly, et al.
Pageof 73